FDA approves aminolevulinic acid hydrochloride as an optical imaging agent indicated in patients with gliomas
admin 21st June 2017 Uncategorised 0European Society for Medical Oncology News
More: FDA approves aminolevulinic acid hydrochloride as an optical imaging agent indicated in patients with gliomas
Source: MDlinx